Cui, Yujun
Liu, Xinzhi
Li, Shuai
Wang, Hongzhi
Xiang, Yirong
Zhang, Yangzi
Song, Maxiaowei
Geng, Jianhao
Liu, Zhiyan
Teng, Huajing
Zhu, Xianggao
Cai, Yong
Li, Yongheng
Wang, Weihu http://orcid.org/0000-0003-4969-398X
Funding for this research was provided by:
Beijing Municipal Science &Technology Commission (Z181100001718192)
Capital’s Funds for Health Improvement and Research (2020-2-1027)
National Natural Science Foundation (82073333)
Beijing Hospitals Authority’s Ascent Plan (DFL20220902)
Peking University Medicine Sailing Program for Young Scholars’ Scientific & Technological Innovation (BMU2023YFJHPY022)
Beijing Hospitals Authority Clinical medicine Development of special funding support (ZLRK202327)
Article History
Received: 21 April 2023
Accepted: 30 October 2023
First Online: 5 December 2023
Declarations
:
: The authors have no potential conflicts of interest to disclose.
: This study was approved by Ethics Committee of Peking University Cancer Hospital and Institute. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: All patients were informed about the risks and benefits of NCRT and provided informed consent to treatment.